ERYTHROMYCINE BAILLEUL 4 %, solution for application cutaneous bottle, 100 ml
Active ingredients: Erythromycin
Commercialized according to BDPMDispensing in France: Prescription only
Solution for applicationbottle, 100 mlcutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ERYTHROMYCINE BAILLEUL 4 %, solution pour application cutanée
- Pharmaceutical form
- solution pour application
- Route of administration
- cutanée
- Presentation description
- 1 flacon(s) polyéthylène téréphtalate blanc de 100 ml
- Marketing authorisation holder
- LABORATOIRES BAILLEUL (LUXEMBOURG)
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 3 Dec 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62856453CIP73311410CIP133400933114107Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉRYTHROMYCINEsolution | 4,00 g · 100 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.